April 19th 2021
press releases
April 16th 2021
press releases
April 14th 2021
investor updates
For a copy of this research report please contact your Bell Potter advisor.
April 9th 2021
analyst reports
April 8th 2021
analyst reports
April 8th 2021
press releases
Upcoming Events
Whats next.
passion.
It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it.
know-how.
Our goal is to gather the strongest forces, the brightest minds and the most dedicated employees.
research.
Accurate research is the strong foundation for developing potential in effective treatment.
What is LAG3?
Lymphocyte-activation gene 3, or LAG-3 (LAG3), is a cell surface molecule with biologic effects on T cell function.
LAG3 is being used for many cancer immunotherapy treatments including Eftilagimod Alpha from Immutep.
